The Food and Drug Administration seeks comments regarding the classification of certain wound care products containing antimicrobials and other drugs, the agency announced today. As a part of the classification process, FDA is seeking input on the indications for use, risks to health, and safety and effectiveness of these wound care products. The General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee will meet Sept. 20 and 21 to discuss and make recommendations on the issue. Background material will be posted before the meeting at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm.

Related News Articles

Headline
More than 880,000 physicians were certified by the American Board of Medical Specialties in 2017, about 20,000 more than in 2016, according to the board’…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…
Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
In a letter this week, the AHA again urged the Centers for Medicare & Medicaid Services to take specific actions to address and prevent the serious…
Headline
AHA has activated The Care Fund to provide support to hospital employees in Puerto Rico who experienced significant property loss or damage from any natural…
Headline
The AHA today urged members of the U.S. Senate “to protect our patients and find ways to maintain coverage for as many Americans as possible” by…